GlaxoSmithKline | GSK - Trade Debtors

Stock Price
2,196.00
Daily Change
29.00 1.34%
Monthly
20.83%
Yearly
49.74%
Q1 Forecast
2,168.74

GlaxoSmithKline reported GBP7.76B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alcon AG USD 1.94B 76M Sep/2025
Almirall EUR 175.93M 17.87M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
argenx SE USD 1.2B 289.13M Jun/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Bayer EUR 14.91B 2.73B Sep/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Fresenius EUR 4.08B 18M Sep/2025
Fresenius Medical Care EUR 3.28B 43.56M Sep/2025
Galapagos EUR 77.67M 145.85M Sep/2025
Genmab DKK 998M 199M Jun/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Glaxosmithkline GBP 11.16B 3.46B Sep/2025
GRIFOLS EUR 1.1B 155.88M Sep/2025
Hikma Pharmaceutical USD 1.11B 133M Jun/2025
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.73B 182M Sep/2025
Merck USD 12.12B 596M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Orion EUR 429.2M 46.9M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Philips EUR 3.8B 266M Dec/2025
Recordati EUR 699.76M 472K Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 397M 100M Dec/2025
Smith & Nephew USD 1.48B 85M Dec/2025
UCB EUR 1.92B 343M Jun/2025